In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma

Cancer Discovery
Matthew J FrankRonald Levy

Abstract

This multicenter phase I/II clinical trial evaluated intratumoral SD-101, a TLR9 agonist, and low-dose radiation in patients with untreated indolent lymphoma. Twenty-nine enrolled patients received 4 Gy of radiation followed by 5 weekly intratumoral injections of SD-101 at a single tumor site. No treatment-related grade 4 or serious adverse events occurred. Nearly all patients had tumor reduction at their treated site. More importantly, 24 patients had tumor reduction at their nontreated sites, with 5 patients achieving a partial response and one achieving a complete response. Treatment-related increases of CD8+ and CD4+ effector T cells and decreases of T follicular helper and T regulatory cells (Treg) were observed in the tumor microenvironment. Low pretreatment levels of CD4+ Tregs, proliferating CD8+ T cells, and Granzyme B+ CD8+ T cells were associated with favorable outcomes. Intratumoral SD-101 in combination with low-dose radiation is well tolerated and results in regression of both treated and untreated sites of disease.Significance:In situ vaccination with the TLR9 agonist SD-101, along with low-dose radiation, was safe and induced systemic responses in patients with indolent lymphoma. Low levels of CD4+ Tregs, prolif...Continue Reading

References

Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Klaus HeckelsmillerGunther Hartmann
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Aug 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jiali LiRonald Levy
Apr 22, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Steve A BroomfieldAndrew J Currie
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joshua D BrodyRonald Levy
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Mar 11, 2011·Nature·Laura PasqualucciRiccardo Dalla-Favera
Apr 6, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ManegoldN Thatcher
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vera HirshJoan H Schiller
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth C SmythRichard D Carvajal
Oct 17, 2012·Cancer Immunology, Immunotherapy : CII·Melanie J McCoyRichard A Lake
May 21, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Seema RawalSattva S Neelapu
Jun 4, 2013·The Journal of Clinical Investigation·Aurélien MarabelleRonald Levy
Sep 26, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manisha SinghWillem W Overwijk
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Michael R GreenAsh A Alizadeh
Apr 16, 2015·Cancer Treatment Reviews·Kobe ReyndersDirk De Ruysscher
Dec 4, 2015·Molecular Oncology·Linda HammerichJoshua D Brody
Feb 11, 2016·Immunotherapy·Linda HammerichJoshua D Brody
Jan 1, 2015·ImmunoTargets and Therapy·Theresa L Whiteside
Nov 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Shu WangCristiana Guiducci
Sep 12, 2017·The New England Journal of Medicine·Jedd D WolchokJames Larkin
Dec 12, 2017·The New England Journal of Medicine·Sattva S NeelapuWilliam Y Go
Feb 2, 2018·Science Translational Medicine·Idit Sagiv-BarfiRonald Levy
Mar 20, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M E Rodríguez-RuizI Melero
Jan 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ManegoldN Thatcher

❮ Previous
Next ❯

Citations

Dec 14, 2018·Blood·Michael S KhodadoustAsh A Alizadeh
Dec 1, 2019·The Oncologist·Omid HamidIgor Puzanov
Mar 18, 2020·Pharmaceutics·María Julia LambertiJessica Dal Col
May 27, 2020·Acta Pharmacologica Sinica·Simon Van Herck, Bruno G De Geest
Jun 9, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Nana DangYuan Lin
Aug 26, 2020·Leukemia & Lymphoma·Zijun Y Xu-Monette, Ken H Young
Sep 27, 2019·Nature Reviews. Drug Discovery·Claire Vanpouille-BoxLorenzo Galluzzi
Apr 20, 2019·Frontiers in Immunology·Nathan SuekDanny N Khalil
Oct 9, 2019·Nature Reviews. Clinical Oncology·Oliver KeppGuido Kroemer
Mar 13, 2020·Nature Reviews. Cancer·Martin McLaughlinKevin J Harrington
Sep 29, 2020·Frontiers in Oncology·Asunción Espinosa-SánchezAmancio Carnero
Jan 6, 2019·Nature Reviews. Drug Discovery·Jérôme Galon, Daniela Bruni
Oct 16, 2019·Frontiers in Immunology·Luciano CastielloFilippo Belardelli
Nov 5, 2020·Antioxidants & Redox Signaling·Congying PuMin Huang
Jan 25, 2020·Cancer Discovery·Annabelle J AnandappaPatrick A Ott
Mar 14, 2019·Cancer Discovery·Patrick A Ott, Catherine J Wu
Jun 7, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M Christina CoxFilippo Belardelli
May 28, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark AleynickJoshua D Brody
Dec 25, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·René BrunoJin Y Jin
Feb 20, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wan Xing HongRonald Levy
Dec 1, 2020·Journal of the National Cancer Institute·Heather M McGeeJohn R Teijaro
Aug 18, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Adam Yuh LinLeo I Gordon
Dec 20, 2020·Translational Oncology·Ahmed I YounesJames W Welsh
Jan 28, 2021·Pharmaceutics·Marina LuchnerAnita Milicic
Sep 19, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stéphane ChampiatAurélien Marabelle
Sep 4, 2020·Current Opinion in Biotechnology·Maria Ochoa de OlzaFernanda G Herrera
Jan 22, 2021·Cellular & Molecular Immunology·Alberto MantovaniPaola Allavena
Oct 30, 2020·OncoTargets and Therapy·Lilit KarapetyanDiwakar Davar
Jan 19, 2020·Seminars in Cancer Biology·Max M Wattenberg, Gregory L Beatty
Nov 16, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hua ZhangKatherine W Ferrara
Jan 22, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wen XuAlexander M Menzies
Apr 4, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Adam A WaltersKhuloud T Al-Jamal
Nov 29, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhuoran ZhangMarcin Kortylewski
Mar 13, 2020·The Oncologist·Omid HamidIgor Puzanov
Jul 16, 2020·Immunity·Sarah M McWhirter, Caroline A Jefferies
Apr 1, 2021·Brachytherapy·Justin C JagodinskyZachary S Morris
Apr 16, 2021·Advanced Drug Delivery Reviews·M Brittany JohnsonKirill A Afonin
Apr 29, 2021·Nature Reviews. Cancer·Mansi SaxenaNina Bhardwaj
May 7, 2021·Science Advances·Jinjin ChenQiaobing Xu
Aug 10, 2020·International Journal of Radiation Oncology, Biology, Physics·Hsuan-Chen LiuAlessandro Grattoni
May 11, 2021·Frontiers in Oncology·Jonathan KhalifaElizabeth Cohen-Jonathan Moyal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.